Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Human Microbiome Market by Type (Gastrointestinal Tract Human Micobiome, Urogenital Tract Human Micobiome, Other), By Application (Treatment, Diagnosis, ) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Human Microbiome Market by Type (Gastrointestinal Tract Human Micobiome, Urogenital Tract Human Micobiome, Other), By Application (Treatment, Diagnosis, ) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 168101 3300 Medical Devices & Consumables 377 236 Pages 4.6 (39)
                                          

Market Overview:


The global human microbiome market is expected to grow at a CAGR of 16.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of lifestyle diseases, growing awareness about the benefits of human microbiome, and rising funding for research on human microbiome. The global human microbiome market is segmented on the basis of type, application, and region. On the basis of type, it is divided into gastrointestinal tract human micobiome, urogenital tract human micobiome, and other types. The gastrointestinal tract segment dominates this market owing to high prevalence of lifestyle diseases such as obesity and diabetes mellitus in developed countries. On the basis of application, it is classified into treatment applications (such as probiotics), diagnosis applications (such as sequencing techniques), and research applications (such as drug discovery).


Global Human Microbiome Industry Outlook


Product Definition:


The human microbiome is the collection of microorganisms that live on and in humans. The importance of the human microbiome is currently being studied, but it is thought that the microbiome may play a role in human health and disease.


Gastrointestinal Tract Human Micobiome:


The gastrointestinal tract (GIT) human microbiome is the collection of bacteria, viruses, fungi and other microorganisms that live in or on the human body. The presence of beneficial microbes in the gut has been linked to several health benefits; including improved immune function, reduced risk for developing certain cancers and metabolic disorders as well as increased absorption of nutrients.


Increasing awareness among consumers regarding gut health and its role in overall wellbeing is one of the key factors driving market growth.


Urogenital Tract Human Micobiome:


The urogenital tract human microbiome is the collection of bacteria, fungi, viruses and other microorganisms that live in or on the human urogenital tract. The main goal of this project is to understand how these communities influence health and disease.


Application Insights:


The application segment of the global human microbiome market is categorized into treatment, diagnosis, and others. The treatment segment dominated the overall market in terms of revenue share in 2017. Increasing prevalence of chronic diseases such as cancer and diabetes along with rising demand for advanced diagnostics techniques are some of the factors driving this segment growth.


The other applications include research & education, food safety & security, industrial manufacturing processes etc. These applications are expected to witness significant growth over the forecast period due to increasing R&D activities pertaining to human microbiome studies across various industries worldwide. For instance; pharmaceutical companies are conducting extensive R&D on gut microbes for developing new drugs while biotechnology firms focus on improving crop yield through innovative tools like metagenomics etc., which is further anticipated to boost product demand over forecast period ¢â‚¬Å“2030¢â‚¬ (read more).


Regional Analysis:


North America dominated the global market in 2017. This can be attributed to the presence of a large number of research laboratories and hospitals that are engaged in studies related to human microbiome. Moreover, increasing government initiatives for mapping out new treatment avenues based on microbial communities is expected to fuel regional growth over the forecast period.


Asia Pacific region is anticipated to witness lucrative growth during the forecast period owing to rising awareness among people about their health and well-being, coupled with an increase in disposable income levels that have resulted into better access of healthcare services resulting into improved diagnosis rates leading towards increased adoption of diagnostic techniques such as 16S rDNA sequencing for characterization of bacterial communities present within various body sites (i.e., gastrointestinal tract, urogenital tract). These factors are likely to contribute towards regional demand during the forecast period  (2018 - 2030).


Latin America also has a significant role regarding development.


Growth Factors:


  • Increasing research and development activities for the human microbiome market.
  • Growing demand for probiotics and prebiotics products owing to their health benefits.
  • Rising number of private and public initiatives to promote gut health awareness among people worldwide.
  • Proliferation of digital technologies that would help in early diagnosis of gut-related diseases through precision medicine approaches. 5) Increasing investments by key players to expand their product portfolios and strengthen their market positions

Scope Of The Report

Report Attributes

Report Details

Report Title

Human Microbiome Market Research Report

By Type

Gastrointestinal Tract Human Micobiome, Urogenital Tract Human Micobiome, Other

By Application

Treatment, Diagnosis,

By Companies

Vedanta, Seres Therapeutics, Second Genome, Rebiotix, ActoGeniX, Enterome BioScience, AvidBiotics, 4D Pharma Research Ltd, Enterologics, Metabogen, Metabiomics, Ritter Pharmaceuticals, Osel, Symberix, Miomics, Symbiotix Biotherapies, MicroBiome Therapeutics LLC,

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

236

Number of Tables & Figures

166

Customization Available

Yes, the report can be customized as per your need.


Global Human Microbiome Market Report Segments:

The global Human Microbiome market is segmented on the basis of:

Types

Gastrointestinal Tract Human Micobiome, Urogenital Tract Human Micobiome, Other

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Treatment, Diagnosis,

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Vedanta
  2. Seres Therapeutics
  3. Second Genome
  4. Rebiotix
  5. ActoGeniX
  6. Enterome BioScience
  7. AvidBiotics
  8. 4D Pharma Research Ltd
  9. Enterologics
  10. Metabogen
  11. Metabiomics
  12. Ritter Pharmaceuticals
  13. Osel
  14. Symberix
  15. Miomics
  16. Symbiotix Biotherapies
  17. MicroBiome Therapeutics LLC

Global Human Microbiome Market Overview


Highlights of The Human Microbiome Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Gastrointestinal Tract Human Micobiome
    2. Urogenital Tract Human Micobiome
    3. Other
  1. By Application:

    1. Treatment
    2. Diagnosis
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Human Microbiome Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Human Microbiome Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


The human microbiome refers to the trillions of bacteria, viruses, and other microorganisms that live in and on the human body. These microbes play an important role in health and can help protect against infections, promote digestion, and support immune function. The microbiome is also thought to play a role in chronic diseases such as obesity or asthma.

Some of the key players operating in the human microbiome market are Vedanta, Seres Therapeutics, Second Genome, Rebiotix, ActoGeniX, Enterome BioScience, AvidBiotics, 4D Pharma Research Ltd, Enterologics, Metabogen, Metabiomics, Ritter Pharmaceuticals, Osel, Symberix, Miomics, Symbiotix Biotherapies, MicroBiome Therapeutics LLC.

The human microbiome market is expected to register a CAGR of 16.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Human Microbiome Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Human Microbiome Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Human Microbiome Market - Supply Chain
   4.5. Global Human Microbiome Market Forecast
      4.5.1. Human Microbiome Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Human Microbiome Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Human Microbiome Market Absolute $ Opportunity

5. Global Human Microbiome Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Human Microbiome Market Size and Volume Forecast by Type
      5.3.1. Gastrointestinal Tract Human Micobiome
      5.3.2. Urogenital Tract Human Micobiome
      5.3.3. Other
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Human Microbiome Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Human Microbiome Market Size and Volume Forecast by Application
      6.3.1. Treatment
      6.3.2. Diagnosis
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Human Microbiome Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Human Microbiome Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Human Microbiome Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Human Microbiome Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Human Microbiome Demand Share Forecast, 2019-2026

9. North America Human Microbiome Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Human Microbiome Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Human Microbiome Market Size and Volume Forecast by Application
      9.4.1. Treatment
      9.4.2. Diagnosis
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Human Microbiome Market Size and Volume Forecast by Type
      9.7.1. Gastrointestinal Tract Human Micobiome
      9.7.2. Urogenital Tract Human Micobiome
      9.7.3. Other
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Human Microbiome Demand Share Forecast, 2019-2026

10. Latin America Human Microbiome Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Human Microbiome Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Human Microbiome Market Size and Volume Forecast by Application
      10.4.1. Treatment
      10.4.2. Diagnosis
    10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Human Microbiome Market Size and Volume Forecast by Type
      10.7.1. Gastrointestinal Tract Human Micobiome
      10.7.2. Urogenital Tract Human Micobiome
      10.7.3. Other
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Human Microbiome Demand Share Forecast, 2019-2026

11. Europe Human Microbiome Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Human Microbiome Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Human Microbiome Market Size and Volume Forecast by Application
      11.4.1. Treatment
      11.4.2. Diagnosis
    11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Human Microbiome Market Size and Volume Forecast by Type
      11.7.1. Gastrointestinal Tract Human Micobiome
      11.7.2. Urogenital Tract Human Micobiome
      11.7.3. Other
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveess/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Human Microbiome Demand Share, 2019-2026

12. Asia Pacific Human Microbiome Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Human Microbiome Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Human Microbiome Market Size and Volume Forecast by Application
      12.4.1. Treatment
      12.4.2. Diagnosis
    12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Human Microbiome Market Size and Volume Forecast by Type
      12.7.1. Gastrointestinal Tract Human Micobiome
      12.7.2. Urogenital Tract Human Micobiome
      12.7.3. Other
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Human Microbiome Demand Share, 2019-2026

13. Middle East & Africa Human Microbiome Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Human Microbiome Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Human Microbiome Market Size and Volume Forecast by Application
      13.4.1. Treatment
      13.4.2. Diagnosis
    13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Human Microbiome Market Size and Volume Forecast by Type
      13.7.1. Gastrointestinal Tract Human Micobiome
      13.7.2. Urogenital Tract Human Micobiome
      13.7.3. Other
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Human Microbiome Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Human Microbiome Market: Market Share Analysis
   14.2. Human Microbiome Distributors and Customers
   14.3. Human Microbiome Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Vedanta
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Seres Therapeutics
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Second Genome
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Rebiotix
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. ActoGeniX
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Enterome BioScience
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. AvidBiotics
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. 4D Pharma Research Ltd
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Enterologics
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Metabogen
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. Metabiomics
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. Ritter Pharmaceuticals
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. Osel
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. Symberix
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. Miomics
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. Symbiotix Biotherapies
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. MicroBiome Therapeutics LLC
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. 
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us